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INTRODUCTION 
Osteoarthritis is the most common sort 
of arthritis that high level of disability 
resulting from disease put it at the top of 
major causes of disability in elderly. 
Osteoarthritis often involved cervical and 
lumbar vertebrate and sacrum, hip, knee, 
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ABSTRACT 
Background and aims: Osteoarthritis is one of the most common arthritis in elderly. No 
confirmed cure is found for it and current treatments have only analgesic effect. In this 
study, it was evaluated to compare the effect of topical application of Eugenia 
caryophylata extract and topical diclofenac and placebo in primary knee osteoarthritis. 
Methods: This randomized double-blind clinical trial study was carried out upon 105 
patients with primary knee osteoarthritis. Patients were selected randomly and divided 
into 3 groups. The first group was given three times 1 mg diclofenac 1% of one mg, the 
second group was given 1mg topical caryophylata 10% of 1 mg three times daily and 
third group was given 1 mg placebo 1 mg three times daily. For three groups, WOMAC 
questionnaire  
(overall pain, knee pain, morning stiffness, stiffness during day, physical activity) were 
completed pretreatment, one week and three and four weeks post-treatment. The data 
were analyzed by SPSS through ANOVA and chi-square tests. 
Results: In this study, the data collected from 105 individuals were analyzed in 3 groups. 
The findings indicated that there is a significant decrease in overall pain (P=0.005), 
stiffness during day (P=0.001), morning stiffness (P=0.001) and knee pain (P=0.017) and 
physical activity (P=0.001) in four weeks after the initiation of treatment in three groups 
of topical Eugenia caryophylata, diclofenac and placebo (P<0.001). In all the three 
groups, mean overall score of WOMAC questionnaire was significantly decreased 
(P<0.001). No side effect related to the intake of medication in 3 groups was observed. 
Conclusion: Extract of Eugenia caryophylata is effective in decreasing knee pain, 
morning stiffness, and stiffness during day and improvement of physical activity in 
patients with knee osteoarthritis and it can be used alongside of chemical medication to 
reduce symptoms of patients in knee osteoarthritis. 
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first metatarsophalangeal joint, hands, the 
distal to proximal joints, and the thumb 
proximal.
1
 
Osteoarthritis is a disease with high 
heritability, but the rate of heritability is 
varied based on the joint. Heritability 
section of knee osteoarthritis is maximum 
30%, but this pervasive osteoarthritis 
phenotype is rarely inherited, and it is 
mostly of the consequences of aging.
2
 In 
the U.S, it is predicted that by 2020, the 
rate of prevalence of osteoarthritis will 
increase up to 66-100%.
1
 
In some countries as Iran, knee 
osteoarthritis is more common due to 
certain habits that cause pressure on the 
knee joint, and it also appears at an early 
age.
3
 Osteoarthritis can be also diagnosed 
based on clinical symptoms, physical 
examination and radiographic signs.
5
 
The rate of prevalence of osteoarthritis 
has a significant relationship with age. 
Osteoarthritis is rarely occurred in adults 
under the age of 40 years and is very 
common in people aged more than 60 
years. Radiographic evidence suggests that 
osteoarthritis is common in the low back 
and neck.
1,3
 
The presence of antioxidative material 
in the diet can prevent or delay 
osteoarthritis. Injuries result from reactive 
oxygen species show that the most 
important among them is Nitric oxide 
compounds. Progression of knee 
osteoarthritis in people who have vitamin 
C deficiency is 3 times higher than those 
with its high intake. Besides, vitamin D 
deficiency is associated with the further 
progress of radiological osteoarthritis.
5
 
Carnation as a spice and medicine in 
Chinese and Hindi medicine is used in 
cases as toothache or rheumatism.
6,7,8
 
Some researchers believe that the 
analgesic effect of Eugenia caryophylata 
probably plays a function through 
inhibition of arachidonic acid metabolism 
and inhibition of histamine secretion and 
in consequence, reduction of inflammatory 
response would occurs.
9-11
 On the other 
hand, some researchers believe that 
eugenol and other similar compounds of 
capsaicin have similar function and their 
receptors place at the end of axons of 
primary afferents of posterior horn 
throughout the spinal cord and may apply 
analgesic effect of eugenol through this 
similarity.
12,13
 
According to the fact that eugenol 
derivatives have agonistic and blocking 
effect on the Adrenergic receptors and 
these receptors have important effect on 
Analgesic systems, it seems that besides 
peripheral inhibition of afferent fibers of 
pain, eugenol affects centrally spine and 
results in increases in analgesia.
14
 
The best treatment for osteoarthritis is 
often obtained through trial and error and 
each patient shows idiosyncratic reactions 
to specific treatments. Gels or creams of 
topical medications containing analgesia 
or non-steroidal anti-inflammatory drug 
can be named.
1
 Due to the properties and 
nature of Carnation and hot and dry vs. 
cold and wet nature of knee osteoarthritis 
and the increasing tendency of the people 
to medicinal herbs, it can be used as an 
alternative for Diclofenac. Therefore, this 
study aimed to compare the effect of topical 
application of Eugenia caryophylata extract 
with topical Diclofenac and placebo of knee 
on knee osteoarthritis. 
 
METHODS 
This double-blind clinical trial study 
was carried out on patients with early knee 
osteoarthritis. The population of this study 
was the patients referred to educational 
clinic of Shahrekord University of Medical 
Sciences that were selected by  
non-probability sampling, under supervision 
of the orthopedic specialist in 2013. 
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The inclusion criteria were minimum 
age of 30 years and maximum age of 60 
years with approved knee osteoarthritis, 
not relieved severity pain based on the 
clinical symptoms despite of regular 
medical treatment and examination for 3 
months. Exclusion criteria was the 
existence of simultaneous severe diseases 
such as gastrointestinal and metabolic 
diseases, fluctuating doses of drugs during 
the study, severe infection, allergy to 
Eugenia caryophylata extract, pregnancy, 
lactation, impaired liver tests. It should be 
noted that intra-articular injection of 
corticosteroids within 5 weeks does not 
cause any problem. 
In this study, 120 patients were 
enrolled and were randomly divided into 3 
groups of 40 patients. The first group used 
ointment of Carnation 10% with the dose of 
1 mg. The second group used diclofenac 1% 
three times daily and the third group used 
topical ointment containing placebo 3 times 
daily and each time at a dose of 1 mg. 
Not to find any problem for the 
patients during the study, analgesic-like 
drug like naproxen 500 mg was 
administered. According to the type of the 
study that was double-blind clinical trial, 
patients who received drug and orthopedist 
who prescribed the drug were not aware of 
the types of drugs administered to patients. 
To achieve this purpose, having 
diagnosed and selected the patients by 
orthopedist, and the patient was referred to 
an individual and Eugenia caryophylata 
and topical diclofenac and placebo 
ointment were randomly distributed 
between patients and each person was 
given a code and the codes were recorded 
in the predetermined tables and completed 
the number of patients. The codes and 
tables were returned to the related 
orthopedist. Extract of Eugenia 
caryophylata plant was prepared in the 
Research Center of Medicinal Plant in 
Shahrekord University of Medical 
Sciences and having weighed, it was 
prepared with the ointment 10% with 
paraffin and glycerol base. Topical 
diclofenac 1% and placebo ointment was 
taken from pharmacies with glycerin and 
paraffin base without any additive. All the 
patients were followed up for a month in 4 
periods of time, including before treatment 
and one week and 3 and 4 weeks after 
receiving the ointment. 
Follow-up was in a way that patients 
who were able to visit in person, come to 
the place otherwise they were followed via 
phone and WOMAC questionnaire was 
completed by patients at every turn. 
During follow-up, 14 subjects were 
excluded from the study. In addition to the 
WOMAC questionnaire, visual analogue 
score questionnaires (VAS score) were 
also completed in every turn of follow-up. 
WOMAC scales under study included the 
pain, stiffness intensity (Stiffness) 
immediately after waking up, stiffness 
after sitting, sleeping or resting, physical 
performance in different activities. The 
collected Data were analyzed by SPSS 
software using ANOVA and chi-square 
test. 
 
Results 
Of the 120 patients who participated 
in this study, 15 patients were excluded 
due to withdraw from the cooperation. The 
data related to 105 patients were finally 
analyzed. In diclofenac group (n=35), 
62.9% were women (n=22) and 37.1% 
were male (n=13). In Carnation group 
(n=35), 74.3% were female (n=26) and 
25.7% were men (n=9). In the placebo 
group (n=35), 57.15% were female (n=20) 
and 85.42% were male (n=15) (P>0.05) 
(Table 1). 
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Table 1: Comparison of mean in WOMAC questionnaire index in 3 groups under study 
P-value Diclofenac group Carnation group Placebo group  Variables 
Mean ± SD Mean ± SD Mean ± SD 
0.79 12.11±2.7 12±4.37 12.5±2.4 General pain severity First 
examination 0.076 4.82±1.6 5.01±1.9 4.11±2.01 Knee pain 
0.119 2.17±1.01 2.34±1.08 2.6±0.9 Morning stiffness 
0.116 2±0.9 2.17±0.95 2.42±0.75 Stiffness in sitting 
0.329 40.7±7.5 38.22±12.08 41.42±7.9 Physical performance 
0.09 11.45±2.7 10.7±4.5 12.5±2.6 General pain severity Second 
examination 0.045 4.5±1.57 4.6±1.55 3.8±1.1 Knee pain 
0.49 2±1 2.2±1.64 2.34±0.8 Morning stiffness 
0.34 1.85±1 1.88±1 2.14±0.77 Stiffness in sitting 
0.017 37.6±7.01 34.8±12 41.14±7.6 Physical performance 
0.006 9.17±3.25 9.71±5.25 12.11±3.16 General pain severity Third 
examination 0.438 3.42±1.26 3.8±1.8 3.37±1.45 Knee pain 
0.017 1.57±0.94 1.71±0.92 2.22±1.08 Morning stiffness 
0.009 1.34±0.83 1.7±1 2.05±0.93 Stiffness in sitting 
0.002 30.9±8.4 32.5±13.6 40.3±8.1 Physical performance 
0.005 7.77±3.63 9±5.9 12.25±3.4 General pain severity Fourth 
examination 0.017 2.74±1.2 3.82±2.05 3.6±1.6 Knee pain 
0.009 1.22±1 1.74±1.03 2.34±1.23 Morning stiffness 
0.001 0.91±0.83 1.48±1.1 1.9±1.2 Stiffness in sitting 
0.001 26±10 30.25±14.6 40±8.6 Physical performance 
 
In diclofenac, Eugenia caryophylata, 
and placebo group, 45.7%, 57.1%and 51.4% 
of patients were in the age group between 50 
and 60 years respectively. In diclofenac, 
Eugenia caryophylata, and placebo group, 
37.1%, 22.9% and 34.2% of patients were 
employed respectively. 
The majority of patients in 3 groups 
were the undergraduate and married 
individuals (Table 2). 
 
Table 2: Frequency distribution of demographic variables of patients in 3 groups (Q-square test) 
P-value Diclofenac n)%( Carnation n)%( Placebo n)%( Groups 
Variables 
0.54 5(14.3) 3(8.6) 4(11.4) 30-40 years Age 
14(40) 12(34.2) 3(37.15) 40-50 years 
(45.7)16 (57.1)20 (51.4)18 50-60 years 
0.62 (62.9)22 (74.3)26 (57.15)20 Female Sex 
(37.1)13 (25.7)9 (42.85)15 Male 
0.43 (37.1)13 (22.9)8 34.20)12 Employed Job 
7(20) (14.3)5 (17.1)6 Labor 
7(20) (17.1)6 (17.1)6 Self employed 
(22.9)8 (45.1)16 (35.2)11 Others 
0.88 14(40) (40)14 (37.15)13 Undergraduate Education 
(28.6)10 (34.2)12 (37.15)13 Diploma 
(31.4)11 25.7))9 (25.7)9 Graduate 
0.63 8(22.9) 5(14.3) 6(17.1) Single Marital status 
(77.1)27 (85.7)30 (82.9)29 Married 
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According to results of the Q-square 
test, no significant difference was 
observed between the two groups based on 
age, sex and body mass index (BMI) in 
subjects (P>0.05). 
Based on analysis of variance test, the 
mean of WOMAC questionnaire showed 
no significant difference (general pain 
severity, knee pain, morning stiffness, 
stiffness in sitting, sleeping, resting and 
physical performance) on the first 
examination or before treatment in group 3 
(P>0.05). 
At the second visit or one week after 
initiation of treatment, physical 
performance was significant in Eugenia 
caryophylata group between diclofenac 
and placebo groups (P=0.017) and there 
was no significant difference in group 3 as 
the other cases(general pain, knee pain, 
morning stiffness, stiffness sitting, 
sleeping and resting) (P>0.05). 
In the third examination or 3 weeks 
after initiation of treatment, general pain 
severity, morning stiffness, stiffness in 
sitting and sleeping in diclofenac group 
was significantly lower than in those of 
two other  groups (P<0.05). 
In addition, in the fourth examination 
or 4 weeks after initiation of treatment, 
general pain severity, knee pain, morning 
stiffness, stiffness in sitting and sleeping 
manners in diclofenac group was 
significantly lower than those which were 
reported in the two groups (P<0.01). 
According to ANOVA, repeated 
observations and comparison in the 3 
groups during the first to fourth 
examination, generally, mean score of 
WOMAC questionnaire (general pain, 
knee pain, morning stiffness, stiffness in 
sitting and sleeping and resting and 
physical performance) in all 3 groups 
(diclofenac, Eugenia caryophylata and 
placebo) decreased significantly during the 
first to fourth examination (P<0.001). 
DISCUSSION 
In this study, the effect of topical 
ointment of Carnation comparing to 
diclofenac ointment group, a nonsteroidal 
anti-inflammatory drug (NSAID), and 
placebo group on reducing symptoms of 
primary knee osteoarthritis was examined. 
The results indicate that general pain 
severity of the patient was reduced 
significantly in the third and fourth weeks 
of the study. 
Decrease in pain was in both 
diclofenac and Eugenia caryophylata 
groups. However, this pain reduction was 
more significant in the group receiving 
topical diclofenac and it was not 
significant placebo group. 
Besides, in the case of knee pain, it 
was significantly reduced in the first and 
fourth weeks that this pain reduction was 
observed in both diclofenac and Eugenia 
caryophylata groups that decrease in knee 
pain was more remarkable in diclofenac 
ointment group and no significant change 
was observed in the placebo group. 
Given to stiffness in sitting, standing, 
and resting, there was a significant 
decrease in the third and fourth weeks that 
this reduction was observed in both 
diclofenac and Eugenia caryophylata 
group and pain reduction was higher in 
diclofenac group than that of Eugenia 
caryophylata. 
Considering to the physical performance 
of the patients participating in this study, 
physical activity increased in both 
diclofenac and Eugenia caryophylata 
groups, but this increase in physical activity 
was more remarkable in diclofenac group. 
Analgesic and anti-inflammatory 
effects of Carnation was confirmed in 
vitro and on animals studies several years 
ago. Many studies have been conducted on 
the properties of Carnation. 
In a study, the effects of carbamazepine 
and diclofenac and placebo in 
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osteoarthritis knee pain relief was 
compared and it was shown that regarding 
to the comparison of the effect of 
carbamazepine and diclofenac in pain 
relief, the severity of pain reduced to the 
same proportion and there was no significant 
difference
15 
that this is in line with our 
findings. In addition, in another study that 
has been carried out in Shahrekord 
University of Medical Sciences on analgesic 
effect of Eugenia caryophylata through 
intrathecal injection upon mice. It is 
suggested that the depth and duration of 
analgesia was dose-dependent and 10 min 
after administration of eugenol, the 
analgesic effect was started and 30 minutes 
after administration, maximum analgesic 
effect was observed.
16
 
Besides, in another study that has been 
done in Shahid Bahonar University of 
Kerman on analgesic properties of eugenol 
(main component of carnation), analgesic 
effect of Eugenia caryophylata has been 
demonstrated using formalin test on rats.
17
 
Many studies have been done on the 
effects of herbal medicines to reduce the 
pain of knee osteoarthritis compared with 
NSAID drugs. However, a few studies have 
been conducted on the effect of carnation 
upon knee osteoarthritis.
18
 
 
CONCLUSION 
Regarding to the determination of the 
effect of Carnation plant extract comparing 
to topical diclofenac upon reducing pain, 
morning stiffness and stiffness during the 
daily activities and its impact on improving 
physical performance of patients in this 
study, it is shown that carnation was 
effective in the decrease of general pain, 
morning stiffness, knee stiffness and 
improvement of physical performance but 
the effect was not as diclofenac ointment. 
Thus, it is suggested that this drug is 
used as an adjunctive therapy in cases that 
NSAID is used to reduce the dosage and 
NSAID’s side effects. 
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